|
Real-time Estimate
Cboe BZX
02:54:04 2026-09-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 8.615 USD | -0.98% |
|
+6.10% | +10.45% |
| Market Cap | 2.22B 1.94B 1.83B 1.66B 3.11B 213B 3.13B 21.93B 8.46B 108B 8.35B 8.17B 349B | P/E 2026 * |
-3.79x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.22B 1.94B 1.83B 1.66B 3.11B 213B 3.13B 21.93B 8.46B 108B 8.35B 8.17B 349B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 3.02x |
| Free-Float |
94.77% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCRX | Delayed | |
CBOE
| BCRX | Real-time | |
|
Tradegate
| BO1 | Real-time | |
|
Mexican S.E.
| BCRX * | End-of-day quote | |
|
Boerse Muenchen
| BO1 | Real-time | |
|
Deutsche Boerse AG
| BO1 | Delayed | |
|
Börse Stuttgart
| BO1 | Delayed | |
|
Berne S.E.
| BO1 | End-of-day quote |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -0.86% | ||
| 1 week | +6.10% | ||
| Current month | -11.19% | ||
| 1 month | -11.19% | ||
| 3 months | -4.17% | ||
| 6 months | -5.95% | ||
| Current year | +10.45% |
| 1 week | 8.02 |  | 8.84 |
| 1 month | 8.02 | | 10.23 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 2025-12-31 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 2025-07-06 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 2026-04-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 2006-12-31 |
Theresa Heggie
BRD | Director/Board Member | 64 | 2018-12-02 |
Charles Gayer
BRD | Director/Board Member | 55 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Free | Director | 644 | 0.0003% | ||
| 8/31/26 | Free | Director | 644 | 0.0003% | ||
| 8/31/26 | Free | Director | 1,288 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | +6.10% | +8.23% | +14.41% | 2.22B | |
| -0.31% | +3.56% | +46.40% | +100.50% | 70.89B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.32B | |
| -3.00% | -6.45% | -17.00% | +355.99% | 27.07B | |
| -2.94% | -0.80% | -0.36% | -12.00% | 24.78B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.59B | |
| -1.26% | -10.61% | +170.72% | +290.48% | 15.52B | |
| -0.91% | +3.55% | +43.66% | +172.18% | 14.49B | |
| -1.21% | -0.03% | -8.76% | +869.34% | 14.14B | |
| -1.16% | -1.00% | +20.06% | +223.48% | 12.35B | |
| Average | -1.05% | +2.01% | +33.11% | +207.97% | 26.44B | |
| Weighted average by Cap. | -0.77% | +1.42% | +35.38% | +163.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 702M 612M 578M 525M 984M 67.38B 988M 6.93B 2.67B 34.26B 2.64B 2.58B 110B | 737M 643M 607M 551M 1.03B 70.75B 1.04B 7.27B 2.81B 35.97B 2.77B 2.71B 116B |
| Net income | -579M -505M -477M -433M -811M -55.53B -814M -5.71B -2.2B -28.23B -2.17B -2.13B -90.85B | 184M 161M 152M 138M 258M 17.7B 259M 1.82B 702M 9B 693M 677M 28.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | $8.615 | -0.98% | 2,222,429 |
| 26-09-17 | $8.700 | +3.20% | 5,220,505 |
| 26-09-16 | $8.430 | +3.31% | 5,860,006 |
| 26-09-15 | $8.160 | -0.85% | 6,113,064 |
| 26-09-14 | $8.230 | +1.35% | 5,096,672 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
